CONTEXT: Continuing the theme of under-representation in clinical trials that develop new treatments, especially in oncology, this article reports on the discussion at the European Hematology Association (EHA) 2021 Virtual Continue Reading
CONTEXT: Report of a poster presentation at the virtual Association for Research in Vision and Ophthamology meeting detailing real-world data on Xiidra effects on treating dry-eye. IMPACT: Low READ Continue Reading
CONTEXT: Report from India the the manufacturers of the Covaxin, Bharat Biotech will be conducting “Phase-4 clinical trials” to check it’s real-world effectiveness. It is probably worth noting that they Continue Reading
CONTEXT: Following on from Ciox partnering with HealthVerity back in February 2021, Datavant (fresh from partnering with Biodesix on a lung cancer database) have announced a $7billion deal to combine Continue Reading
CONTEXT: We’ve covered reports around this theme before, so good to see further research supporting why it is important to have representative ethnic diversity in all studies on new therapies, Continue Reading
CONTEXT: Report from ASCO 2021 from the MYLUNG Consortium research study in metastatic NSCLC. The findings based on the results from the first of 5 protocols is a retrospective review Continue Reading
CONTEXT: Report of a peer reviewed study published in the journal “Therapeutic Advances in Endocrinology and Metabolism” (TAEM) on subcutaneous testosterone pellets for long term hormone therapy in men and Continue Reading
CONTEXT: As promised, we will keep you up to date on the FDA guidance on RWE in pediatric oncology. It seems the guidance will be available soon, but following a Continue Reading
CONTEXT: Commercial announcement of a collaboration on RWE generation in migraine. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 6 1. “” Our ongoing partnership enables Continue Reading
CONTEXT: Commercial announcement of a collaboration on RWE generation in migraine. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 – 10]: 6 1. “” Our ongoing partnership enables Continue Reading
